Navigation Links
Proven™ Posterior Stabilized Knee System

ProductsProven™ Posterior Stabilized Knee System
Company StelKast Company
Item Proven™ Posterior Stabilized Knee System
Features 
  • Three peg or one peg option.
  • Rounded dome geometry to enhance congruency.
  • Uniform peg location allows intra-operative size change.
  • Description StelKast's Proven™ knee system is a long term, quality solution based on a clinically proven design. Available in both posterior stabilized and anatomically correct cruciate retaining configurations. In addition, instrument standardization and ease of identification keeps the user in mind and promotes functional efficiency.
    Info StelKast Company
    Customer Service: (888) 273-1583
    Web site: http://www.stelkast.com/

    Related medicine products :

    1. Proven™ Cruciate Retaining Knee System
    2. Holladay Posterior Capsule Polisher and Curette
    3. Posterior Capsule Polisher, 23 g
    4. Posterior Capsule Polisher, 21 g
    5. Simcoe Posterior Chamber Lens Forceps
    6. Spine-Tract Posterior Lumbar Retractor System
    7. Image-Trac Posterior Spine Retractor System
    8. Graftech Posterior Ramp
    9. Tangent Posterior Impacted Instrument Set
    10. TANGENT Posterior Impacted Instrument Set
    11. PLIG (Posterior Lumbar Interbody Graft) Instruments
    ...r provides effective therapy at an affordable pric...home or on the go and features ease of use, a 5-ye...ave come to count on from DeVilbiss., ,The PulmoA... those patients seeking a quality, effective treat...
    ...th low to moderate pain in one or more limbs assoc...d back. This may include people with post laminect...isc surgery or degenerative disc disease and Compl...s+ was designed to give patients more control over...
    TurboFlow™ System 3000 Insufflator, 10 liter
    KLEPPINGER tongs
    Medicine Products:
    (Date:11/23/2009)...wire/--CortivaInstituteTucsonwillhostanIntroductio...attheschool,s6390EastBroadwayBlvd.location,whichwi...cticebasicmassagestrokes. ,, "Massagetherapyisa...talongwithit,"saidJoannMcMaster,presidentofCortiva...abor,s2009-2010OccupationalOutlookHandbookstatesth...
    (Date:11/23/2009)...ewswire/--InasurveyofNewJerseyandPhiladelphiaregio...,72percentdonotbelieveanewhealthcarebillwouldlikel...oresultsofthelatestsurveyconductedbytheAlloySilver...toppedthelistat85percentasthebiggestnationalissue....nttocompaniesfromallpartsofNewJerseyandSoutheaster...
    (Date:11/23/2009)...ience Writings at Stevens Institute of Technology ...ert Wright, journalist and founder, Bloggingheads.... the Babbio Center for Technology Management, Room... the media., In his new book "The Evolution of G...owned for his popular works on evolutionary psycho...
    (Date:11/23/2009)...l errors self-reported by American surgeons are st...se findings appear today in the online edition of ...luded collaborators from Johns Hopkins and the Ame...ial study, nearly 9 percent of U.S. surgeons respo...nths prior to being surveyed. Over 70 percent attr...
    (Date:11/23/2009)...s Diseases Society of America (IDSA) has asked for...e European Union to further the Society,s mission ...ithin the next 10 years, known as the 10 x ,20 Ini...identified antimicrobial resistance as one of the ...European Union report confirms there are just 15 a...
    Breaking Medicine News(10 mins):Health News:Cortiva Institute To Host Workshop, Hands-On Opportunity for Prospective Students 2Health News:Burnout and mental distress strongly related to errors by US surgeons 2Health News:10 x '20: ID experts call for 10 new antibiotics by 2020 2Health News:10 x '20: ID experts call for 10 new antibiotics by 2020 3
    ... molecule that is part of a complex signaling netw...e in periventricular heterotopia (PVH), a congenit...earchers report in Neuron. PVH often leads t...ses, but is most commonly due to mutations in the ...
    ...tarbucks are now determined to stop the use of dai...th hormone (rBGH) at all of their stores. //Severa... cream, eggnog etc., which contain rBGH are no lon...BGH milk products to eliminate trans-fatty acids f...
    ... recent research finding indicates that patients w...er rate of relapse of multiple sclerosis (MS). Mul...rms the myelin sheath that covers the nerve fibres...als of Neurology. A study was conducted by them am...
    ...t is an act of gratitude, and Nathan Hartley is on...s one of four brothers, all who had been diagnosed...are genetic defect, in November 2003. X-linked...ses the immune system to respond abnormally to som...
    ...anadian scientists claim to have found a substitut...bearable side effects like nausea and fatigue. The...ournal Cancer Cell. // The scientists seemed to...and consumed. The greater advantage of DCA is its ...
    ... new surgical technique pioneered at the Universit... to patients with tongue cancer.// By modify...from a patient's forearm to his tongue, surgeons c...along with the tissue and skin of the forearm to r...
    Other Medicine News:Health News:Missing Molecule Has Important Role in a Developmental Brain Abnormality 2Health News:Big Brother to the Rescue 2Health News:'Beavertail' Surgery Helps Tongue Cancer Patients 2Health News:'Beavertail' Surgery Helps Tongue Cancer Patients 3
    (Date:11/23/2009)..., NOVATO,Calif.,Nov.23/PRNewswire-FirstCall/--Rapt...aq: RPTP ),todayannouncedresultsfromaPhase2bclinic...tartrate("DRCysteamine")inpatientswithnephropathic...iversityofCalifornia,SanDiego("UCSD")GeneralClinic...macokineticsandpharmacodynamicsofasingledoseofDRCy...
    (Date:11/23/2009)..., EMERYVILLE,Calif.,Nov.23/PRNewswire-FirstCall/--...TI")announcedtodaythatitsboardofdirectorshasdeclar...ock,whichwillbepaidonDecember9,2009tostockholderso...rdinarydividendfollowsstockholderapprovalofthediss...ddissolutionandanearlierextraordinarydividendof$0....
    (Date:11/20/2009)..., WAYNE, Pa., Nov. 20 ...nced the results for its fiscal first quarter ende...r of fiscal 2010, product revenue decreased approx...e three-month period ended September 30, 2009 as c...Company reported the decreased net revenue of $8,4...
    Breaking Medicine Technology:Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis 2Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis 3Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis 4Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis 5Neurobiological Technologies Announces Extraordinary Dividend of $0.18 per Share 2Escalon(R) Reports First Quarter Fiscal 2010 Results 2Escalon(R) Reports First Quarter Fiscal 2010 Results 3Escalon(R) Reports First Quarter Fiscal 2010 Results 4Escalon(R) Reports First Quarter Fiscal 2010 Results 5Escalon(R) Reports First Quarter Fiscal 2010 Results 6Escalon(R) Reports First Quarter Fiscal 2010 Results 7Number of Underweight Kids in U S Continues to Shrink 51798 1AHIMA Launches New Interactive myPHR com Web Site 51796 1AHIMA Launches New Interactive myPHR com Web Site 51796 2AHIMA Launches New Interactive myPHR com Web Site 51796 3Netsmart Technologies Acquires Pharmacy Management Software Company 51795 1Netsmart Technologies Acquires Pharmacy Management Software Company 51795 2Netsmart Technologies Acquires Pharmacy Management Software Company 51795 3